Your browser is no longer supported. Please, upgrade your browser.
Settings
INSY INSYS Therapeutics, Inc. daily Stock Chart
INSY [NASD]
INSYS Therapeutics, Inc.
Index- P/E22.88 EPS (ttm)0.70 Insider Own0.20% Shs Outstand70.49M Perf Week6.48%
Market Cap1.12B Forward P/E18.38 EPS next Y0.87 Insider Trans33.03% Shs Float22.76M Perf Month24.80%
Income52.90M PEG0.82 EPS next Q0.07 Inst Own55.00% Short Float76.40% Perf Quarter-1.05%
Sales322.00M P/S3.49 EPS this Y49.20% Inst Trans2.27% Short Ratio24.03 Perf Half Y-29.58%
Book/sh3.49 P/B4.57 EPS next Y141.11% ROA16.70% Target Price24.40 Perf Year-63.95%
Cash/sh2.32 P/C6.87 EPS next 5Y28.00% ROE22.40% 52W Range11.45 - 46.17 Perf YTD-44.29%
Dividend- P/FCF13.15 EPS past 5Y28.50% ROI22.80% 52W High-65.45% Beta1.95
Dividend %- Quick Ratio2.80 Sales past 5Y- Gross Margin91.60% 52W Low39.30% ATR0.77
Employees510 Current Ratio3.30 Sales Q/Q-12.40% Oper. Margin25.80% RSI (14)62.51 Volatility4.04% 5.83%
OptionableYes Debt/Eq0.00 EPS Q/Q-69.50% Profit Margin16.40% Rel Volume0.82 Prev Close15.62
ShortableYes LT Debt/Eq0.00 EarningsAug 04 BMO Payout0.00% Avg Volume723.50K Price15.95
Recom1.80 SMA2012.53% SMA5011.16% SMA200-20.05% Volume592,562 Change2.11%
Apr-12-16Reiterated Jefferies Buy $23 → $17
Apr-11-16Reiterated Piper Jaffray Overweight $46 → $28
Feb-24-16Reiterated Jefferies Buy $36 → $23
Feb-01-16Reiterated RBC Capital Mkts Outperform $49 → $44
Mar-09-15Reiterated RBC Capital Mkts Outperform $65 → $71
Mar-04-15Reiterated RBC Capital Mkts Outperform $57 → $65
Dec-15-14Reiterated RBC Capital Mkts Outperform $53 → $57
Nov-12-14Reiterated RBC Capital Mkts Outperform $51 → $53
Nov-12-14Downgrade Oppenheimer Outperform → Perform $40
Oct-02-14Initiated RBC Capital Mkts Outperform $51
Aug-14-13Reiterated Oppenheimer Outperform $23 → $27
Jul-31-13Initiated Oppenheimer Outperform $23
Jul-22-16 04:38PM  The Marijuana Industry Is Growing Like Weeds
10:07AM  Huge Drugmaker Fines for Bribing Healthcare Providers at Motley Fool
Jul-20-16 04:30PM  Insys Therapeutics to Report Second Quarter 2016 Results GlobeNewswire
04:20PM  This Marijuana Drugmaker Sets Its Sights on a 9-Figure Market at Motley Fool
Jul-19-16 09:04AM  How Do Healthcare Companies Market Their Products? at Motley Fool
Jul-18-16 08:30AM  Pharmaceutical Studies & Trials of Individual Cannabinoids Aim to Develop Cannabis Strains That Specifically Target Cancer Pain and Nausea CNW Group
Jul-08-16 09:15AM  Recent Market Movers - Eleven Biotherapeutics Insys Therapeutics Himax Technologies and Broadcom
Jul-06-16 09:20AM  Coverage of Top Gainers Leading Brands Himax Technologies and Insys Therapeutics
08:07AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : July 6, 2016
Jul-05-16 06:32PM  Goldman Sachs, Halliburton and Delta fall; Clorox climbs +6.90%
05:07PM  Why Insys Therapeutics, Endeavour Silver, and Himax Technologies Jumped Today at Motley Fool
04:21PM  Insys Stock Jumps As FDA Approves Appetite-Boosting Cannabis Drug
03:42PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
03:04PM  FDA Approves Insys Therapeutics' 2nd Cannabis-Based Drug at Forbes
02:52PM  What's Got This Marijuana Stock Jumping Double-Digits Today at Motley Fool
02:45PM  Insys Therapeutics (INSY) Stock Soars on FDA Approval
01:55PM  Biotech Movers: Insys Therapeutics Inc (INSY) and Cempra Inc (CEMP) at Insider Monkey
09:16AM  Insys's stock soars after cannabis-based oral drug gets FDA approval at MarketWatch
08:40AM  Insys Soars on Huge FDA Win at 24/7 Wall St.
08:12AM  Insys Therapeutics: FDA Approves Treatment for AIDS Symptoms at The Wall Street Journal
06:55AM  Insys Therapeutics Announces FDA Approval of Syndros GlobeNewswire
06:43AM  Top Bets of Parametrica Management Barrons Penta No. 1 Fund at Insider Monkey
Jul-01-16 09:00AM  Zeldes Haeggquist & Eck, LLP Announces Investigation of INSYS Therapeutics, Inc. Business Wire
Jun-27-16 04:11PM  GW Pharma Jumps As Cannabis Drug Treats Severe Epilepsy -9.19%
Jun-21-16 09:00AM  Buy Insys Therapeutics Before Medical Marijuana Reaches A Tipping Point at Forbes
Jun-20-16 05:22PM  Which Stocks To Watch Ahead Of The Potential Us-Wide Federal Legalization Of Medical Cannabis
Jun-13-16 08:19AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : INSY-US : June 13, 2016
Jun-10-16 03:28PM  Former Insys employees charged in doctor kickback scheme at CNBC -12.73%
Jun-03-16 07:16PM  Weeding Out the Winners in Race for Cannabis-Based Drugs -7.24%
May-28-16 03:11PM  How Hedge Funds Traded Marijuana Stocks in Q1 at Insider Monkey
May-26-16 04:30PM  Insys Therapeutics, Inc. to Present at Two Upcoming Conferences in June GlobeNewswire
08:20AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : May 26, 2016
May-24-16 09:00PM  This Marijuana Stock Takes a Step Forward at Motley Fool +6.07%
06:50AM  Insys Therapeutics Successfully Completes Safety and Pharmacokinetic (PK) Study of Cannabidiol Oral Solution in Pediatric Epilepsy Patients GlobeNewswire
May-18-16 03:40PM  4 Top Stocks in the Growing Medical Marijuana Industry
09:26AM  4 Best Stocks in the Thriving Medical Marijuana Industry at TheStreet
May-16-16 04:00PM  Repros Announces the Appointment of Mr. Patrick Fourteau as Chairman of the Board GlobeNewswire
May-13-16 03:43PM  What You Need To Know About Investing In Marijuana Stocks at Motley Fool
May-12-16 01:04PM  INSYS THERAPEUTICS, INC. Financials
May-10-16 02:22PM  Here's Why Insys Therapeutics Inc. Fell 14.3% in April at Motley Fool
May-09-16 06:04PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submiss
May-05-16 06:11AM  INSYS THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
May-02-16 01:14PM  INSYS Therapeutics, Inc. :INSY-US: Earnings Analysis: Q1, 2016 By the Numbers
Apr-28-16 03:05PM  Edited Transcript of INSY earnings conference call or presentation 28-Apr-16 2:00pm GMT
10:36AM  Insys Therapeutics beats Street 1Q forecasts AP
09:02AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
07:07AM  Q1 2016 INSYS Therapeutics Inc Earnings Release - Before Market Open CCBN
06:50AM  Insys Therapeutics Reports First Quarter 2016 Results GlobeNewswire
Apr-26-16 04:30PM  Insys Therapeutics, Inc. to Present at Deutsche Bank 41st Annual Health Care Conference GlobeNewswire
Apr-25-16 01:45PM  5 Earnings Stocks Everyone Hates but You Should Love at TheStreet
Apr-18-16 10:20AM  Biotech and Pharmaceuticals Highlight Jefferies Top Growth Stock Buys at 24/7 Wall St. +5.03%
Apr-15-16 05:59PM  What Falling Estimates & Price Mean for INSYS Therapeutics (INSY)
11:48AM  These 3 Marijuana-Related Stocks Are Poised for Strong Growth at TheStreet
Apr-14-16 04:30PM  Insys Therapeutics to Report First Quarter 2016 Results GlobeNewswire
Apr-13-16 07:00PM  Cramer: These stocks hit me like a snake bite at CNBC
02:02PM  Roddy Boyd Nailed Insys Therapeutics Thesis
07:49AM  Markets Fall on Earnings Worry: Biotech Stocks Follow Suit
12:47AM  [$$] Pharma Guidance Is Bad, Timing Is Worse at The Wall Street Journal
Apr-12-16 12:49PM  [$$] Pharma Guidance Is Bad, Timing Is Worse at The Wall Street Journal
11:25AM  Endo Pharmaceuticals: The Most Attractive Valeant-Like Company? at Barrons.com
Apr-11-16 05:02PM  Stocks Reverse Lower; Alcoa Earnings Top Views -19.37%
03:56PM  What Has Insys Theraepeutics Shares Crashing 20% Today at Motley Fool
03:37PM  Insys Therapeutics (INSY) Stock Tanks on Preliminary Subsys Revenues at TheStreet
01:11PM  Endo International Tumbles as Insys Expects Weak Painkiller Sales at TheStreet
12:06PM  Why These 5 Stocks Are Trending Ahead of Earnings Season Kickoff at Insider Monkey
09:05AM  Insys Therapeutics Sinks on Missed Revenue Estimates at 24/7 Wall St.
09:04AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
06:50AM  Insys Therapeutics Reports Preliminary Estimated Revenues from Subsys for the First Quarter 2016 GlobeNewswire
Apr-06-16 12:43PM  The truth about Denver, revealed by a 25-year-old Denver native +10.18%
08:19AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : INSY-US : April 6, 2016
Apr-01-16 04:44PM  Scott + Scott, LLP Reminds Investors of April 4, 2016 Deadline to File Lead Plaintiff Papers in Insys Therapeutics (INSY) Securities Case GlobeNewswire +5.69%
03:30PM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Notifies Shareholders of INSYS Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of April 4, 2016 INSY GlobeNewswire
02:10PM  Insys Therapeutics - Final Deadline Reminder Accesswire
Mar-30-16 12:41PM  April 4 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Lead Plaintiff Deadline in the Class Action Lawsuit Against Insys Therapeutics, Inc. and Encourages Investors to Contact the Firm Business Wire
09:00AM  Important Lead Plaintiff Deadline Reminder For Insys Therapeutics Shareholders PR Newswire
Mar-29-16 01:40PM  SECURITIES ALERT: Rosen Law Firm Reminds INSYS Therapeutics, Inc. Investors of Important April 4, 2016 Deadline in Class Action INSY GlobeNewswire
Mar-28-16 02:22PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Insys Therapeutics, Inc. To Contact The Firm Before Imminent Lead Plaintiff Deadline Accesswire
11:19AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of INSYS Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of April 4, 2016 Business Wire
08:04AM  SECURITIES FRAUD ALERT: The Law Firm of Andrews & Springer LLC Announces That A Securities Fraud Class Action Has Been Filed Against Insys Therapeutics, Inc. - INSY GlobeNewswire
Mar-26-16 09:15AM  SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Insys Therapeutics, Inc - INSY PR Newswire
Mar-24-16 09:00AM  Insys Shareholder Alert: Lawsuit Filed By Kessler Topaz Meltzer & Check LLP Against Insys Therapeutics Accesswire
Mar-23-16 01:52PM  INSYS Therapeutics, Inc. Value Analysis (NASDAQ:INSY) : March 23, 2016 -14.86%
08:30AM  Hagens Berman Reminds Insys Therapeutics Inc. (NASDAQ: INSY) Investors of April 4, 2016 Lead Plaintiff Deadline in Shareholder Class Action Lawsuit GlobeNewswire
Mar-22-16 05:04PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +8.83%
04:05PM  Insys Therapeutics, Inc. Announces 3-Month Extension of PDUFA Date for Syndros GlobeNewswire
08:05AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : March 22, 2016
Mar-21-16 11:56AM  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving INSYS Therapeutics, Inc. and a Lead Plaintiff Deadline of April 4, 2016 Business Wire
Mar-19-16 12:02PM  3 Emerging Biotech Stocks I'm Watching Like a Hawk at Motley Fool
Mar-18-16 10:03PM  The Former Attorney General of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against Insys Therapeutics, Inc. - INSY PR Newswire +5.89%
05:30PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Insys Therapeutics, Inc. To Contact The Firm Before Lead Plaintiff Deadline PR Newswire
03:26PM  INSY INVESTOR REMINDER: Class Action Deadline Reminder From Lieff Cabraser for Investors in Insys Therapeutics, Inc. Business Wire
10:02AM  Shareholder Lawsuit Filed Against Insys Therapeutics: Kessler Topaz Meltzer & Check LLP GlobeNewswire
09:03AM  Of These 5 Hated Biotech Stocks, Only 1 Is a Potential Disaster in the Making at Motley Fool
Mar-16-16 12:19PM  Hedge Funds Think These 4 Marijuana Stocks Are Pretty Dope at Insider Monkey
11:12AM  INVESTOR ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving INSYS Therapeutics, Inc. and a Lead Plaintiff Deadline of April 4, 2016 - INSY PR Newswire
Mar-15-16 04:15PM  INSYS Therapeutics, Inc.: Gathering momentum, can it sustain its performance? -6.25%
12:21PM  A Huge Breakthrough For Medical Marijuana at Motley Fool
11:30AM  Scott + Scott, LLP Reminds Investors of April 4, 2016 Deadline to File Lead Plaintiff Papers in Insys Therapeutics (INSY) Securities Case GlobeNewswire
08:00AM  INSYS Therapeutics (INSY) Looks Good: Stock Up 11.4%
Mar-14-16 04:50PM  GW Pharma Stock Rockets As Cannabis Drug Fights Epilepsy +11.38%
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is Syndros, an orally administered liquid formulation of dronabinol. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood catastrophic epilepsy syndromes; and other product candidates, including other dronabinol line extensions and sublingual spray product candidates. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MEYER STEVEN JDirectorJul 06Option Exercise14.4469510,03632,389Jul 06 04:12 PM
MEYER STEVEN JDirectorJun 07Option Exercise14.081,19416,80631,694Jun 07 09:33 PM
BAKER DARRYL SChief Financial OfficerMay 23Option Exercise13.5710,000135,70021,030May 23 04:40 PM
MEYER STEVEN JDirectorMay 18Option Exercise13.575006,78530,500May 18 04:39 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerMay 12Buy12.4110,000124,11942,424,610May 12 07:06 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerMay 11Buy12.9440,000517,70842,414,610May 12 07:06 PM
MEYER STEVEN JDirectorApr 14Option Exercise4.8712,00058,47030,000Apr 14 06:54 PM
FOURTEAU PATRICKDirectorMar 04Sale18.2215,000273,30064,682Mar 04 04:52 PM
MEYER STEVEN JDirectorFeb 05Option Exercise8.3218,000149,83018,000Feb 09 02:12 PM
FOURTEAU PATRICKDirectorNov 12Sale26.4830,000794,40079,682Nov 13 03:38 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerNov 11Buy25.5210,000255,22142,359,610Nov 13 03:25 PM
Babich Michael LPresident and CEOSep 22Option Exercise1.6216,06826,030421,572Sep 22 06:36 PM
STANLEY THEODORE HDirectorSep 14Option Exercise3.632,0007,2604,000Sep 14 05:24 PM
STANLEY THEODORE HDirectorSep 14Sale38.082,00076,1602,000Sep 14 05:24 PM
STANLEY THEODORE HDirectorSep 10Option Exercise3.632,0007,2604,000Sep 14 05:24 PM
STANLEY THEODORE HDirectorSep 10Sale36.002,00072,0072,000Sep 14 05:24 PM